Nectar Lifesciences Limited (NSE:NECLIFE)
India · Delayed Price · Currency is INR 12.67
+0.26 (2.10%)
Apr 17, 2026, 3:29 PM IST
Nectar Lifesciences Market Cap
Nectar Lifesciences has a market cap or net worth of 2.46 billion as of April 17, 2026. Its market cap has decreased by -54.19% in one year.
Market Cap
2.46B
Enterprise Value
6.99B
Revenue
16.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
12.67
Market Cap Chart
Since July 18, 2005, Nectar Lifesciences's market cap has decreased from 2.87B to 2.46B, a decrease of -14.10%. That is a compound annual growth rate of -0.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.46B | -43.46% |
| Dec 31, 2025 | 4.35B | -50.21% |
| Dec 31, 2024 | 8.74B | 21.24% |
| Dec 29, 2023 | 7.21B | 30.96% |
| Dec 30, 2022 | 5.51B | -8.40% |
| Dec 31, 2021 | 6.01B | 12.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 13.21B |
| Jagsonpal Pharmaceuticals | 12.89B |
| Ind-Swift Laboratories | 11.43B |
| Sigachi Industries | 8.92B |
| Valiant Laboratories | 3.71B |
| Bafna Pharmaceuticals | 3.30B |
| Brooks Laboratories | 1.99B |
| Alpa Laboratories | 1.45B |